Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Key facts

Study ID

NCT04140695

Run by

Vanda Pharmaceuticals

People needed

87

Starts

2019-10-21

Expected to finish

2020-10-14

Last updated by the study team

2024-05-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and non-pregnant, non-lactating female patients aged 18 - 70 years (inclusive);
• Diagnosed with atopic dermatitis;
• Suffering from chronic pruritus;
• Body Mass Index (BMI) of ≥18 and ≤40 kg/m2

You may not qualify if…

• Chronic pruritus due to condition other than atopic dermatitis (AD);
• A positive test for drugs of abuse at the screening or evaluation visits;
• Exposure to any investigational medication in the past 60 days

Where it is running

• Vanda Investigational Site — Tempe, Arizona, United States
• Vanda Investigational Site — Encino, California, United States
• Vanda Investigational Site — Fountain Valley, California, United States
• Vanda Investigational Site — Laguna Hills, California, United States
• Vanda Investigational Site — Lomita, California, United States
• Vanda Investigational Site — Los Angeles, California, United States
• Vanda Investigational Site — Los Angeles, California, United States
• Vanda Investigational Site — Los Angeles, California, United States
• Vanda Investigational Site — Denver, Colorado, United States
• Vanda Investigational Site — Clearwater, Florida, United States
• Vanda Investigational Site — Miami, Florida, United States
• Vanda Investigational Site — Tampa, Florida, United States
• Vanda Investigational Site — Savannah, Georgia, United States
• Vanda Investigational Site — Boise, Idaho, United States
• Vanda Investigational Site — Chicago, Illinois, United States
• Vanda Investigational Site — Normal, Illinois, United States
• Vanda Investigational Site — Skokie, Illinois, United States
• Vanda Investigational Site — Plainfield, Indiana, United States
• Vanda Investigational Site — Crowley, Louisiana, United States
• Vanda Investigational Site — Timonium, Maryland, United States
• Vanda Investigational Site — Fort Gratiot, Michigan, United States
• Vanda Investigational Site — Saint Joseph, Missouri, United States
• Vanda Investigational Site — St Louis, Missouri, United States
• Vanda Investigational Site — Omaha, Nebraska, United States
• Vanda Investigational Site — Hoover, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.